Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» September 2010
September 2010
Odds Increase for Approval of Incyte's Myelofibrosis Drug
Odds Increase for Approval of Incyte's Myelofibrosis Drug
Seeking Alpha
Incyte
myelofibrosis
Novartis
MAP plans to raise $40.9M in stock sale
MAP plans to raise $40.9M in stock sale
Bizjournals.com
stock offering
MAP Pharmaceuticals
Apricus Biosciences drops 20% after unit offering
Apricus Biosciences drops 20% after unit offering
Marketwatch
Apricus Biosciences
Bayer's Dekkers Sees Another Schering-Sized Deal as Financially Possible
Bayer's Dekkers Sees Another Schering-Sized Deal as Financially Possible
Bloomberg
Bayer
M&A
Marijn Dekkers
Pharma CEOs
Rigel Pharma earns $25M AstraZeneca payment tied to potential rheumatoid arthritis treatment
Rigel Pharma earns $25M AstraZeneca payment tied to potential rheumatoid arthritis treatment
Yahoo/AP
Rigel
AstraZeneca
milestone payments
rheumatoid arthritis
fostamatinib
Lilly research chief outlines the perfect biotech pact
Lilly research chief outlines the perfect biotech pact
Fierce Biotech
Eli Lilly
R&D
Endo Pharmaceuticals Holdings shares rise in premarket trading after buyout announcement
Endo Pharmaceuticals Holdings shares rise in premarket trading after buyout announcement
Yahoo/AP
Endo
M&A
Qualitest
Johnson & Johnson's Reputation Begins to Slide
Johnson & Johnson's Reputation Begins to Slide
Seeking Alpha
JNJ
recalls
ZymoGenetics reports positive skin cancer drug results
ZymoGenetics reports positive skin cancer drug results
Bizjournals.com
skin cancer
ZymoGenetics
Interleukin
U.S. Can Continue Stem-Cell Funding, Court Says
U.S. Can Continue Stem-Cell Funding, Court Says
Bloomberg
stem cells
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »